247
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Qualitative Interviews to Support Development and Cognitive Debriefing of the Adelphi Adherence Questionnaire (ADAQ©): A Patient-Reported Measure of Medication Adherence Developed for Use in a Range of Diseases, Treatment Modalities, and Countries

, ORCID Icon, , , , ORCID Icon, ORCID Icon, ORCID Icon & show all
Pages 2579-2592 | Received 12 Jan 2022, Accepted 26 Jul 2022, Published online: 15 Sep 2022

References

  • World Health Organization. Adherence to Long-Term Therapies: Evidence for Action. World Health Organization; 2003.
  • FDA. Are you taking medication as prescribed?; 2009 Available from: https://www.fda.gov/consumers/consumer-updates/are-you-taking-medication-prescribed. Accessed February 18, 2021.
  • Vrijens B, De Geest S, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73(5):691–705. doi:10.1111/j.1365-2125.2012.04167.x
  • Cramer JA, Roy A, Burrell A, et al. Medication compliance and persistence: terminology and definitions. Value Health. 2008;11(1):44–47. doi:10.1111/j.1524-4733.2007.00213.x
  • Gast A, Mathes T. Medication adherence influencing factors—an (updated) overview of systematic reviews. Syst Rev. 2019;8(1):1–17. doi:10.1186/s13643-019-1014-8
  • Steiner JF, Earnest MA. The language of medication-taking. Ann Intern Med. 2000;132(11):926–930. doi:10.7326/0003-4819-132-11-200006060-00026
  • Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo Clin Proc. 2011;86(4):304–314. doi:10.4065/mcp.2010.0575
  • Cheen MHH, Tan YZ, Oh LF, Wee HL, Thumboo J. Prevalence of and factors associated with primary medication non-adherence in chronic disease: a systematic review and meta-analysis. Int J Clin Pract. 2019;73(6):e13350. doi:10.1111/ijcp.13350
  • Conn VS, Ruppar TM. Medication adherence outcomes of 771 intervention trials: systematic review and meta-analysis. Prev Med. 2017;99:269–276. doi:10.1016/j.ypmed.2017.03.008
  • Jimmy B, Jose J. Patient medication adherence: measures in daily practice. Oman Med J. 2011;26(3):155. doi:10.5001/omj.2011.38
  • Fitzpatrick C, Gillies C, Seidu S, et al. Effect of pragmatic versus explanatory interventions on medication adherence in people with cardiometabolic conditions: a systematic review and meta-analysis. BMJ open. 2020;10(7):e036575. doi:10.1136/bmjopen-2019-036575
  • Dima AL, van Ganse E, Laforest L, Texier N, de Bruin M; ASTRO-LAB Group T. Measuring medication adherence in asthma: development of a novel self-report tool. Psychol Health. 2017;32(10):1288–1307. doi:10.1080/08870446.2017.1290248
  • Kosilov K, Loparev S, Kuzina I, Shakirova O, Zhuravskaya N, Lobodenko A. Self-assessment of treatment compliance with antimuscarinic drugs and lower urinary tract condition among women with urinary incontinence. Int Urogynecol J. 2017;28(11):1663–1669. doi:10.1007/s00192-017-3333-4
  • Sidorkiewicz S, Tran V-T, Cousyn C, Perrodeau E, Ravaud P. Development and validation of an instrument to assess treatment adherence for each individual drug taken by a patient. BMJ open. 2016;6(5):e010510. doi:10.1136/bmjopen-2015-010510
  • Ahmad A, Sorensen K. Enabling and hindering factors influencing adherence to asthma treatment among adolescents: a systematic literature review. J Asthma. 2016;53(8):862–878. doi:10.3109/02770903.2016.1155217
  • Hanghøj S, Boisen KA. Self-reported barriers to medication adherence among chronically ill adolescents: a systematic review. J Adolesc Health. 2014;54(2):121–138. doi:10.1016/j.jadohealth.2013.08.009
  • Huang W-C, Chen C-Y, Lin S-J, Chang C-S. Medication adherence to oral anticancer drugs: systematic review. Expert Rev Anticancer Ther. 2016;16(4):423–432. doi:10.1586/14737140.2016.1159515
  • Macdonald M, Martin-Misener R, Helwig M, et al. Experiences of adults with cystic fibrosis in adhering to medication regimens: a qualitative systematic review. JBI Database Syst Rev Implement Rep. 2016;14(5):258–285. doi:10.11124/JBISRIR-2016-002362
  • McSharry J, McGowan L, Farmer A, French D. Perceptions and experiences of taking oral medications for the treatment of type 2 diabetes mellitus: a systematic review and meta‐synthesis of qualitative studies. Diabetic Med. 2016;33(10):1330–1338. doi:10.1111/dme.13152
  • Rebafka A. Medication adherence after renal transplantation—a review of the literature. J Ren Care. 2016;42(4):239–256. doi:10.1111/jorc.12181
  • Rezaei M, Valiee S, Tahan M, Ebtekar F, Gheshlagh RG. Barriers of medication adherence in patients with type-2 diabetes: a pilot qualitative study. Diabetes Metab Syndr Obes. 2019;12:589. doi:10.2147/DMSO.S197159
  • Dockerty T, Latham S, Smith T. Why don’t patients take their analgesics? A meta-ethnography assessing the perceptions of medication adherence in patients with osteoarthritis. Rheumatol Int. 2016;36(5):731–739. doi:10.1007/s00296-016-3457-8
  • Lin C, Clark R, Tu P, Bosworth HB, Zullig LL. Breast cancer oral anti-cancer medication adherence: a systematic review of psychosocial motivators and barriers. Breast Cancer Res Treat. 2017;165(2):247–260. doi:10.1007/s10549-017-4317-2
  • Vitalis D. Factors affecting antiretroviral therapy adherence among HIV-positive pregnant and postpartum women: an adapted systematic review. Int J Std AIDS. 2013;24(6):427–432. doi:10.1177/0956462412472807
  • Chan W, Chen A, Tiao D, Selinger C, Leong R. Medication adherence in inflammatory bowel disease. Intestinal Res. 2017;15(4):434. doi:10.5217/ir.2017.15.4.434
  • Raebel MA, Schmittdiel J, Karter AJ, Konieczny JL, Steiner JF. Standardizing terminology and definitions of medication adherence and persistence in research employing electronic databases. Med Care. 2013;51(80 3):S11. doi:10.1097/MLR.0b013e31829b1d2a
  • Lam WY, Fresco P. Medication adherence measures: an overview. Biomed Res Int. 2015;2015:1–12. doi:10.1155/2015/217047
  • Farmer KC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther. 1999;21(6):1074–1090. doi:10.1016/S0149-2918(99)80026-5
  • Nguyen TMU, Caze AL, Cottrell N. What are validated self‐report adherence scales really measuring?: a systematic review. Br J Clin Pharmacol. 2014;77(3):427–445. doi:10.1111/bcp.12194
  • Kim C-J, Schlenk EA, Ahn J-A, Kim M, Park E, Park J. Evaluation of the measurement properties of self-reported medication adherence instruments among people at risk for metabolic syndrome: a systematic review. Diabetes Educ. 2016;42(5):618–634. doi:10.1177/0145721716655400
  • Culig J, Leppée M. From Morisky to Hill-bone; self-reports scales for measuring adherence to medication. Coll Antropol. 2014;38(1):55–62.
  • Gagné M, Boulet LP, Pérez N, Moisan J. Patient‐reported outcome instruments that evaluate adherence behaviours in adults with asthma: a systematic review of measurement properties. Br J Clin Pharmacol. 2018;84:1928–1940. doi:10.1111/bcp.13623
  • Pérez-Escamilla B, Franco-Trigo L, Moullin JC, Martínez-Martínez F, García-Corpas JP. Identification of validated questionnaires to measure adherence to pharmacological antihypertensive treatments. Patient Prefer Adherence. 2015;9:569. doi:10.2147/PPA.S76139
  • Mansberger SL, Sheppler CR, McClure TM, et al. Psychometrics of a new questionnaire to assess glaucoma adherence: the glaucoma treatment compliance assessment tool (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc. 2013;111:1.
  • Boas LCG-V, Lima MLSAP, Pace AE. Adherence to treatment for diabetes mellitus: validation of instruments for oral antidiabetics and insulin. Rev Lat Am Enfermagem. 2014;22(1):11–18. doi:10.1590/0104-1169.3155.2386
  • Bou Serhal R, Salameh P, Wakim N, et al. A new Lebanese medication adherence scale: validation in Lebanese hypertensive adults. Int J Hypertens. 2018;2018:3934296. doi:10.1155/2018/3934296
  • Cahir C, Dombrowski SU, Kennedy MJ, Sharp L, Bennett K. Developing and validating a theoretical measure of modifiable influences on hormonal therapy medication taking behaviour in women with breast cancer. Psychol Health. 2017;32(10):1308–1326. doi:10.1080/08870446.2017.1296151
  • de Oliveira Marsicano E, da Silva Fernandes N, Colugnati F, et al. Transcultural adaptation and initial validation of Brazilian-Portuguese version of the Basel assessment of adherence to immunosuppressive medications scale (BAASIS) in kidney transplants. BMC Nephrol. 2013;14(1):108. doi:10.1186/1471-2369-14-108
  • Demirtaş A, Akbayrak N. Development of an assessment scale for treatment compliance in type 2 diabetes mellitus in Turkish population: psychometric evaluation. Int J Nurs Sci. 2017;4(3):244–251. doi:10.1016/j.ijnss.2017.06.002
  • Lehane E, McCarthy G, Collender V, Deasy A, O’Sullivan K. The reasoning and regulating medication adherence instrument for patients with coronary artery disease: development and psychometric evaluation. J Nurs Meas. 2013;21(1):64. doi:10.1891/1061-3749.21.1.64
  • Mayberry LS, Gonzalez JS, Wallston KA, Kripalani S, Osborn CY. The ARMS-D. Out performs the SDSCA, but both are reliable, valid, and predict glycemic control. Diabetes Res Clin Pract. 2013;102(2):96–104. doi:10.1016/j.diabres.2013.09.010
  • Plaza V, Fernández-Rodríguez C, Melero C, et al. Validation of the ‘Test of the Adherence to Inhalers’(TAI) for asthma and COPD patients. J Aerosol Med Pulm Drug Deliv. 2016;29(2):142–152. doi:10.1089/jamp.2015.1212
  • Robinson-Papp J, George MC, Wongmek A, et al. The quantitative analgesic questionnaire: a tool to capture patient-reported chronic pain medication use. J Pain Symptom Manage. 2015;50(3):381–386. doi:10.1016/j.jpainsymman.2015.03.013
  • Rodrigues MTP, Moreira TMM, Andrade D. Elaboration and validation of instrument to assess adherence to hypertension treatment. Rev Saude Publica. 2014;48(2):232–240. doi:10.1590/S0034-8910.2014048005044
  • Schatz M, Zeiger RS, Yang S-J, et al. Development and preliminary validation of the adult asthma adherence questionnaireTM. J Allergy Clin Immunol Pract. 2013;1(3):280–288. doi:10.1016/j.jaip.2013.03.001
  • Teixeira A, Oliveira C, Teixeira M, et al. Development and validation of a novel Questionnaire for Adherence with Topical Treatments in Psoriasis (QATOP). Am J Clin Dermatol. 2017;18(4):571–581. doi:10.1007/s40257-017-0272-2
  • Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67–74. doi:10.1097/00005650-198601000-00007
  • Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens. 2008;10(5):348–354. doi:10.1111/j.1751-7176.2008.07572.x
  • Kripalani S, Risser J, Gatti ME, Jacobson TA. Development and evaluation of the Adherence to Refills and Medications Scale (ARMS) among low-literacy patients with chronic disease. Value Health. 2009;12(1):118–123. doi:10.1111/j.1524-4733.2008.00400.x
  • Risser J, Jacobson TA, Kripalani S. Development and psychometric evaluation of the Self-efficacy for Appropriate Medication Use Scale (SEAMS) in low-literacy patients with chronic disease. J Nurs Meas. 2007;15(3):203. doi:10.1891/106137407783095757
  • Kim MT, Hill MN, Bone LR, Levine DM. Development and testing of the Hill-Bone compliance to high blood pressure therapy scale. Prog Cardiovasc Nurs. 2000;15(3):90–96. doi:10.1111/j.1751-7117.2000.tb00211.x
  • Thompson K, Kulkarni J, Sergejew AA. Reliability and validity of a new Medication Adherence Rating Scale (Mars) for the psychoses. Schizophr Res. 2000;42(3):241–247. doi:10.1016/S0920-9964(99)00130-9
  • Garfield S, Clifford S, Eliasson L, Barber N, Willson A. Suitability of measures of self-reported medication adherence for routine clinical use: a systematic review. BMC Med Res Methodol. 2011;11(1):1–9. doi:10.1186/1471-2288-11-149
  • Unni EJ, Olson JL, Farris KB. Revision and validation of Medication Adherence Reasons Scale (MAR-Scale). Curr Med Res Opin. 2014;30(2):211–221. doi:10.1185/03007995.2013.851075
  • Patrick DL, Burke LB, Gwaltney CJ, et al. Content validity—establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1—eliciting concepts for a new PRO instrument. Value Health. 2011;14(8):967–977. doi:10.1016/j.jval.2011.06.014
  • EMEA. Reflection Paper on the Regulatory Guidance for the Use of Health-Related Quality of Life (HRQL) Measures in the Evaluation of Medicinal Products. London: European Medicines Agency; 2005.
  • FDA Draft Guidance. Patient-focused drug development: methods to identify what is important to patients guidance for industry, food and drug administration staff, and other stakeholders [DRAFT]. US Food and Drug Administration; 2019.
  • FDA Guidance. Patient-focused drug development: collecting comprehensive and representative input; guidance for industry, food and drug administration staff, and other stakeholders. US Food and Drug Administration; 2020.
  • FDA Guidance. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims. US Food and Drug Administration; 2009.
  • Willis GB. Cognitive Interviewing: a tool for improving questionnaire design; 2004.
  • Morgan L, Exall E, Bentley S, et al. Qualitative interviews to explore drivers and behaviours associated with medication non-adherence across a range of diseases, treatment modalities, and countries International Society of Patient Reported Outcomes. (ISPOR) EU; 2020.
  • ATLAS. Scientific software development GmbH version 8 [computer program]; 2020.
  • Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101. doi:10.1191/1478088706qp063oa
  • FDA Draft Guidance. Patient-focused drug development guidance: methods to identify what is important to patients and select, develop or modify fit-for-purpose clinical outcome assessments [DRAFT]. US Food and Drug Administration; 2018.
  • Munro S, Lewin S, Swart T, Volmink J. A review of health behaviour theories: how useful are these for developing interventions to promote long-term medication adherence for TB and HIV/AIDS? BMC Public Health. 2007;7(1):1–16. doi:10.1186/1471-2458-7-104
  • Horne R. Compliance, adherence, and concordance: implications for asthma treatment. Chest. 2006;130(1):65S–72S. doi:10.1378/chest.130.1_suppl.65S
  • Adefolalu AO. Cognitive-behavioural theories and adherence: application and relevance in antiretroviral therapy. South Afr J HIV Med. 2018;19(1):1–7. doi:10.4102/sajhivmed.v19i1.762
  • Rimer BKGK Theory at a glance: application to health promotion and health behaviour. National Cancer Institute. Available from: http://www.cancer.gov/cancertopics/cancerlibrary/theory.pdf. Accessed August 17, 2022.
  • Lavsa SM, Holzworth A, Ansani NT. Selection of a validated scale for measuring medication adherence. J Am Pharm Assoc. 2011;51(1):90–94. doi:10.1331/JAPhA.2011.09154
  • Stull DE, Leidy NK, Parasuraman B, Chassany O. Optimal recall periods for patient-reported outcomes: challenges and potential solutions. Curr Med Res Opin. 2009;25(4):929–942. doi:10.1185/03007990902774765
  • Bhandari A, Wagner T. Self-reported utilization of health care services: improving measurement and accuracy. Med Care Res Rev. 2006;63(2):217–235. doi:10.1177/1077558705285298
  • Jordan S, Watkins A, Storey M, et al. Volunteer bias in recruitment, retention, and blood sample donation in a randomised controlled trial involving mothers and their children at six months and two years: a longitudinal analysis. PLoS One. 2013;8(7):e67912. doi:10.1371/journal.pone.0067912
  • Sackett DL. Bias in analytic research. In: The Case-Control Study Consensus and Controversy. Elsevier; 1979:51–63.
  • Krigsman K, Nilsson JLG, Ring L. Adherence to multiple drug therapies: refill adherence to concomitant use of diabetes and asthma/COPD medication. Pharmacoepidemiol Drug Saf. 2007;16(10):1120–1128. doi:10.1002/pds.1433